SEARCH

SEARCH BY CITATION

Literature Cited

  • 1
    Faich GA. Adverse-drug-reaction monitoring. N Engl J Med 1986;314:15891592.
  • 2
    Dona I, Blanca-Lopez N, Cornejo-Garcia JA, Torres MJ, Laguna JJ, Fernandez J, Rosado A, Rondon C, Campo P, Agundez JA, et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: Patterns of response. Clin Exp Allergy 2011;41:8695.
  • 3
    Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, Bousquet P, Celik G, Demoly P, Gomes ER, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy 2011;66:818829.
  • 4
    Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: Results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996;98:678685.
  • 5
    Carmona MJ, Blanca M, Garcia A, Fernandez S, Burgos F, Miranda A, Vega JM, Garcia J. Intolerance to piroxicam in patients with adverse reactions to nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 1992;90:873879.
  • 6
    de Paramo BJ, Gancedo SQ, Cuevas M, Camo IP, Martin JA, Cosmes EL. Paracetamol (acetaminophen) hypersensitivity. Ann Allergy Asthma Immunol 2000;85:508511.
  • 7
    Blanca M, Perez E, Garcia JJ, Miranda A, Terrados S, Vega JM, Suau R. Angioedema and IgE antibodies to aspirin: A case report. Ann Allergy 1989;62:295298.
  • 8
    Harrer A. Diclofenac-specific monoclonal antibodies show variable cross-reactivity to diclofenac metabolites. EAACI Abstract Book 2007:3536.
  • 9
    Scala E, Giani M, Pirrotta L, Guerra EC, Locanto M, De Pita O, Puddu P. Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal anti-inflammatory drug intolerance. J Allergy Clin Immunol 2001;107:557.
  • 10
    Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, Ebner H, Ebner C. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 2003;111:882888.
  • 11
    Kowalski ML, Bienkiewicz B, Woszczek G, Iwaszkiewicz J, Poniatowska M. Diagnosis of pyrazolone drug sensitivity: Clinical history versus skin testing and in vitro testing. Allergy Asthma Proc 1999;20:347352.
  • 12
    Fontaine C, Bousquet PJ, Demoly P. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole. J Allergy Clin Immunol 2005;115:633634.
  • 13
    Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975;1:6769.
  • 14
    Szczeklik A, Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913921; quiz 922.
  • 15
    Stevenson DD, Simon RA. Sensitivity to aspirin and nosteroidal anti-inflammatory drugs. In: Middleton E, editor. Allergy: Principles & Practice. St. Louis: Mosby; 1998.
  • 16
    Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004;140:10011006.
  • 17
    Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, Kowalski ML, Setkowicz M, Ring J, Brockow K, et al. EAACI/GA2LEN guideline: Aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007;62:11111118.
  • 18
    Sanz ML, Gamboa PM, Antepara I, Uasuf C, Vila L, Garcia-Aviles C, Chazot M, De Weck AL. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 2002;32:277286.
  • 19
    Torres MJ, Padial A, Mayorga C, Fernandez T, Sanchez-Sabate E, Cornejo-Garcia JA, Antunez C, Blanca M. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 2004;34:17681775.
  • 20
    Aranda A, Mayorga C, Ariza A, Dona I, Blanca-Lopez N, Canto G, Blanca M, Torres MJ. IgE-mediated hypersensitivity reactions to methylprednisolone. Allergy 2010;65:13761380.
  • 21
    Aranda A, Mayorga C, Ariza A, Dona I, Rosado A, Blanca-Lopez N, Andreu I, Torres MJ. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 2011;66:247254.
  • 22
    Abuaf N, Rajoely B, Ghazouani E, Levy DA, Pecquet C, Chabane H, Leynadier F. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol 1999;104:411418.
  • 23
    Ebo DG, Bridts CH, Hagendorens MM, Mertens CH, De Clerck LS, Stevens WJ. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide. Allergy 2006;61:935939.
  • 24
    Gamboa PM, Sanz ML, Caballero MR, Antepara I, Urrutia I, Jauregui I, Gonzalez G, Dieguez I, De Weck AL. Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 2003;58:312317.
  • 25
    Gomez E, Blanca-Lopez N, Torres MJ, Requena G, Rondon C, Canto G, Blanca M, Mayorga C. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: Value of basophil activation test in the identification of patients. Clin Exp Allergy 2009;39:12171224.
  • 26
    Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS, Stevens WJ. In vitro allergy diagnosis: Should we follow the flow? Clin Exp Allergy 2004;34:332339.
  • 27
    Rodriguez-Trabado A, Camara-Hijon C, Ramos-Cantarino A, Porcel-Carreno SL, Jimenez-Timon S, Pereira-Navarro G, Hernandez-Arbeiza FJ, Fernandez-Pereira L. Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Proc 2008;29:241249.
  • 28
    Gamboa P, Sanz ML, Caballero MR, Urrutia I, Antepara I, Esparza R, de Weck AL. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy 2004;34:14481457.
  • 29
    Celik GE, Schroeder JT, Hamilton RG, Saini SS, Adkinson NF. Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy 2009;39:15221531.
  • 30
    De Weck AL, Sanz ML, Gamboa PM, Aberer W, Blanca M, Correia S, Erdman S, Jermann JM, Kanny G, Kowalski M, et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. J Investig Allergol Clin Immunol 2009;19:355369.
  • 31
    Szczeklik A N-ME, Sanak M. Hypersensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Adkinson NF, Bochner BS, Holgate ST, Lemanske RF, Simons, FE, editors. Middleton's Allergy Principles and Practice. Philadelphia: Mosby; 2009. pp 12271243.
  • 32
    Blanca-Lopez N, Andreu I, Torres Jaen MJ. Hypersensitivity reactions to quinolones. Curr Opin Allergy Clin Immunol 2011;11:285291.
  • 33
    MacGlashan D, Jr, Schroeder JT. Functional consequences of FcepsilonRIalpha up-regulation by IgE in human basophils. J Leukoc Biol 2000;68:479486.
  • 34
    MacGlashan D, Jr, Xia HZ, Schwartz LB, Gong J. IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils. J Leukoc Biol 2001;70:207218.
  • 35
    Sainte-Laudy J, Boumediene A, Touraine F, Orsel I, Brianchon C, Bonnaud F, Cogne M. Use of both CD63 up regulation and IgE down regulation for the flow cytometric analysis of allergen induced basophil activation. Definition of an activation index. Inflamm Res 2007;56:291296.
  • 36
    Abuaf N, Rostane H, Rajoely B, Gaouar H, Autegarden JE, Leynadier F, Girot R. Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy 2008;38:921928.
  • 37
    Hausmann OV, Gentinetta T, Fux M, Ducrest S, Pichler WJ, Dahinden CA. Robust expression of CCR3 as a single basophil selection marker in flow cytometry. Allergy 2011;66:8591.
  • 38
    de Weck AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, Demoly P, Ebo DG, Mayorga L, Monneret G, et al. Diagnostic tests based on human basophils: More potentials and perspectives than pitfalls. Int Arch Allergy Immunol 2008;146:177189.
  • 39
    Sturm EM, Kranzelbinder B, Heinemann A, Groselj-Strele A, Aberer W, Sturm GJ. CD203c-based basophil activation test in allergy diagnosis: Characteristics and differences to CD63 upregulation. Cytometry B Clin Cytom 2010;78B:308318.
  • 40
    MacGlashan DW, Jr. Basophil activation testing. J Allergy Clin Immunol 2013;132:777787.
  • 41
    Blanca-Lopez N, J Torres M, Dona I, Campo P, Rondon C, Seoane Reula ME, Salas M, Canto G, Blanca M. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Clin Exp Allergy 2013;43:8591.
  • 42
    Nguyen KL, Gillis S, MacGlashan DW, Jr. A comparative study of releasing and nonreleasing human basophils: Nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking. J Allergy Clin Immunol 1990;85:10201029.
  • 43
    Lavens-Phillips SE, MacGlashan DW, Jr. The tyrosine kinases p53/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in nonreleasing human basophils. Am J Respir Cell Mol Biol 2000;23:566571.
  • 44
    Monneret G. CCR3 for basophil activation test: A necessary but insufficient step. Clin Exp Allergy 2010;40:953; author reply 954.
  • 45
    Sainte-Laudy J, Ouk C. Use of lipid rafting for the analysis of human basophil activation by flow cytometry. Inflamm Res 2010;59:S193S195.
  • 46
    Rodriguez Trabado A, Camara Hijon C, Porcel Carreno SL, Rodriguez Martin E, Fletes Peral C, Pereira Navarro G, Jimenez Timon S, Hernandez Arbeiza FJ, Fernandez Pereira L. Anaphylaxis caused by cloxacillin: Diagnosis with seriated analysis by way of basophil activation test. Allergy Asthma Proc 2006;27:269272.
  • 47
    Malbran A, Yeyati E, Rey GL, Galassi N. Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients. Clin Exp Immunol 2007;147:99105.